fashion -WSS

fashion

author：entertainment 2025-10-02 22:24:14 - browse：47

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Flint parents haunted by uncertainty, fears of lead poisoning

WSS

A $475,000 price tag for a new cancer drug: crazy or meh?

ARCH Venture Partners is raising $3 billion for a life sciences fund

How I helped Pfizer think through the ethics of Viagra

The a glaring gap in research on serious mental illness and primary care

What we need to know about Arena Bioworks

A $475,000 price tag for a new cancer drug: crazy or meh?

focus

fashion

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Study links childhood stress with decline in older age

Sports medicine is finally prioritizing gender equality

Even great ERs can’t make up for American health disparities

Continuity nursing helped my family in our darkest PICU moments

ARCH Venture Partners is raising $3 billion for a life sciences fund

23andMe had bad news about my health. I wish a person had delivered it

Chris Christie meets with Zelenskyy during Ukraine trip

Jerome Adams on the need for new antivirals for Covid

H.R. 3 is the wrong path to lower drug costs

focus

Group behind ProMed defends move to subscription

The lessons of Aduhelm, an Alzheimer's drug that was not to be

How to ethically and practically extend health care to all

2 officers injured in shooting in Orlando, police say

Do digital therapeutics have a future in medicine?

The cancer stories no one wants to hear

leisure time

entertainment

Wikipedia

explore